In both genders, PRL excess, specifically when associated with pituitary adenomas, has been associated with a higher risk of MetS, adipose tissue dysfunction index and reduced glucose tolerance, with the normalization of PRL leading to an improved metabolic pattern [44, 45]. Here, PRL is linked to metabolic syndrome.